GO:0052856 NAD(P)HX epimerase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052856 (NAD(P)HX epimerase activity) catalyzes the epimerization of (6R)-NADHX to (6S)-NADHX and (6R)-NADPHX to (6S)-NADPHX, repairing damaged reduced nicotinamide cofactors.
• The enzyme is encoded by NAXE (also known as AIBP) in humans and is highly conserved from bacteria to mammals.
• Loss of NAD(P)HX epimerase activity leads to accumulation of NADHX/NADPHX, which inhibits dehydrogenases and blocks de novo serine synthesis.
• NAD(P)HX epimerase downregulation promotes hepatocellular carcinoma progression through ROS/HIF-1α signaling.
• The enzyme has a moonlighting function in lipid metabolism and angiogenesis, independent of its epimerase activity.
• CRISPR knockout, point mutation, and overexpression models are essential to dissect its dual roles in metabolite repair and disease.
Description
NAD(P)HX epimerase activity (GO:0052856) is a molecular function that repairs damaged reduced nicotinamide adenine dinucleotide (NADH) and its phosphorylated form (NADPH) by converting the (6R) epimers to the (6S) epimers. This activity is essential because NADH and NADPH are central electron carriers in metabolism, and their non-enzymatic hydration produces (6R)-NADHX and (6R)-NADPHX, which are inhibitory to many dehydrogenases. The enzyme responsible, NAD(P)HX epimerase, is encoded by the NAXE gene in humans (also known as AIBP) and is conserved across all domains of life. Researchers study this term to understand how cells maintain cofactor pools, how defects contribute to disease such as cancer and neurodegeneration, and how the enzyme's moonlighting functions in lipid metabolism and angiogenesis intersect with its repair role. The dual functionality of NAXE makes it a compelling target for CRISPR-based functional genomics.
NAD(P)HX epimerase activity At A Glance
| GO ID | GO:0052856 |
|---|---|
| GO term | NAD(P)HX epimerase activity |
| Ontology | molecular_function |
| Synonym | NADHX epimerase activity, NADPHX epimerase activity |
| Definition | Catalysis of the reactions: (6R)-NADHX = (6S)-NADHX and (6R)-NADPHX = (6S)-NADPHX. |
| Major function | Repair of damaged NADH/NADPH by epimerization of (6R) to (6S) forms |
| Cellular location | Cytoplasm and mitochondria (inferred from substrate availability) |
| Enzyme class | Epimerase (isomerase) |
| Human gene | NAXE (AIBP) |
What Is GO:0052856?
NAD(P)HX epimerase activity (GO:0052856) is defined as the catalysis of the reactions: (6R)-NADHX = (6S)-NADHX and (6R)-NADPHX = (6S)-NADPHX. In other words, it is an epimerase that interconverts the R and S stereoisomers of hydrated NADH and NADPH, specifically at the C6 position of the nicotinamide ring. This activity is part of the NAD(P)H repair pathway, which also includes a dehydratase (NAXD) that converts the S epimers back to NADH/NADPH.
Why Is NAD(P)HX epimerase activity Important in Cell Biology?
NAD(P)HX epimerase activity is critical for cellular metabolism because it prevents the accumulation of damaged NADH/NADPH, which can inhibit key dehydrogenases and disrupt redox homeostasis. Its dysfunction has been linked to cancer progression, where downregulation of NAXE promotes tumor growth via ROS/HIF-1α signaling. Additionally, the enzyme's moonlighting role in cholesterol efflux and angiogenesis highlights its broader physiological significance. Understanding this activity is therefore essential for researchers in metabolism, cancer biology, and cardiovascular disease.
• Maintains functional NADH/NADPH pools by repairing spontaneous hydration damage.
• Prevents inhibition of dehydrogenases by (6R)-NADHX and (6R)-NADPHX.
• Downregulation is associated with poor prognosis in hepatocellular carcinoma.
• Moonlighting function in lipid metabolism and angiogenesis, independent of epimerase activity.
• Mutations in NAXE cause NAD(P)HX repair deficiency, a rare neurometabolic disorder.
• Plays a role in de novo serine synthesis, linking cofactor repair to one-carbon metabolism.
• Potential therapeutic target for cancers with metabolic reprogramming.
• Involved in ketone and lipid metabolism regulation.
• Conserved across evolution, making it a model for metabolite repair studies.
• CRISPR screens can identify synthetic lethal interactions with NAD(P)HX repair pathways.
Molecular Mechanism of NAD(P)HX epimerase activity
Substrate Recognition and Binding
In simple terms: The enzyme grabs the damaged NADH/NADPH molecule.
NAD(P)HX epimerase specifically binds (6R)-NADHX and (6R)-NADPHX, the hydrated forms of NADH and NADPH that arise from non-enzymatic damage. The binding site accommodates the nicotinamide ring and the adenosine moiety, ensuring specificity for the reduced cofactor.
Catalytic Epimerization
In simple terms: It flips the shape of the damaged molecule to a usable form.
The enzyme catalyzes the inversion of stereochemistry at the C6 position of the nicotinamide ring, converting (6R)-NADHX to (6S)-NADHX and (6R)-NADPHX to (6S)-NADPHX. This epimerization is a reversible reaction and does not require cofactors or ATP.
Coupling to Dehydratase for Full Repair
In simple terms: Another enzyme finishes the repair job.
The (6S) epimers produced by NAD(P)HX epimerase are subsequently dehydrated by NAD(P)HX dehydratase (NAXD) to regenerate NADH and NADPH. This two-step pathway ensures efficient recycling of damaged cofactors.
Moonlighting Functions
In simple terms: The enzyme has a second job outside of repair.
Beyond its epimerase activity, NAXE (AIBP) can bind to apolipoprotein A-I and regulate cholesterol efflux, angiogenesis, and lipid metabolism. This moonlighting function is independent of the catalytic epimerase domain.
Regulation of Activity
In simple terms: The cell controls how much of this enzyme is made.
NAD(P)HX epimerase expression is regulated at the transcriptional level and can be downregulated in cancer, as seen in hepatocellular carcinoma where reduced NAXE levels correlate with tumor progression. The enzyme's activity may also be influenced by substrate availability and redox state.
Key Genes Involved in GO:0052856 NAD(P)HX epimerase activity
The following genes and proteins are directly involved in NAD(P)HX epimerase activity or its repair pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NAXE (AIBP) | Encodes NAD(P)HX epimerase; catalyzes epimerization of (6R)-NADHX/NADPHX | Downregulated in hepatocellular carcinoma; moonlighting roles in lipid metabolism |
| NAXD | NAD(P)HX dehydratase; converts (6S)-NADHX/NADPHX to NADH/NADPH | Partners with NAXE in NAD(P)H repair pathway |
| HIF1A | Hypoxia-inducible factor 1-alpha; downstream effector of ROS signaling | Mediates tumor progression upon NAXE loss |
| APOA1 | Apolipoprotein A-I; interacts with AIBP/NAXE | Regulates cholesterol efflux and angiogenesis |
| VEGFA | Vascular endothelial growth factor A; involved in angiogenesis | Modulated by AIBP/NAXE in endothelial cells |
| LDHA | Lactate dehydrogenase A; sensitive to NADH/NADPH imbalance | Potential target of NAD(P)HX accumulation |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase; glycolytic enzyme | Inhibited by (6R)-NADHX |
| PHGDH | Phosphoglycerate dehydrogenase; key enzyme in serine synthesis | Blocked by damaged NAD(P)H, linking repair to serine metabolism |
| PSAT1 | Phosphoserine aminotransferase; serine synthesis | Affected by NAD(P)HX repair deficiency |
| PSPH | Phosphoserine phosphatase; serine synthesis | Downstream of NAD(P)HX repair |
| SLC1A4 | Glutamine transporter; may influence NAD(P)H metabolism | Indirectly linked to cofactor balance |
| SLC7A11 | Cystine/glutamate antiporter; redox balance | Modulates oxidative stress upon NAXE loss |
| NFE2L2 | NRF2; antioxidant response transcription factor | May compensate for NAXE deficiency |
| PPARGC1A | PGC-1α; mitochondrial biogenesis regulator | Linked to NAD(P)H homeostasis |
| SREBF1 | SREBP1; lipogenic transcription factor | Regulated by AIBP/NAXE in lipid metabolism |
| ABCA1 | Cholesterol efflux transporter | Interacts with AIBP/NAXE pathway |
| CASP3 | Caspase-3; apoptosis executioner | Activated upon severe NAD(P)HX accumulation |
How Is NAD(P)HX epimerase activity Regulated?
NAD(P)HX epimerase activity is primarily regulated by the expression level of the NAXE gene. In hepatocellular carcinoma, NAXE is downregulated, leading to reduced epimerase activity and increased ROS/HIF-1α signaling. The enzyme's activity can also be influenced by the availability of its substrates, (6R)-NADHX and (6R)-NADPHX, which accumulate under oxidative stress. Additionally, the moonlighting function of NAXE in lipid metabolism is regulated by interactions with apolipoprotein A-I and may be modulated by inflammatory signals.
NAD(P)HX epimerase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NAXE | Hepatocellular carcinoma | NAXE knockout HepG2 cells; xenograft mouse models |
| NAXE | NAD(P)HX repair deficiency | Patient-derived fibroblasts; CRISPR knock-in of patient mutations |
| NAXE | Atherosclerosis / angiogenesis | AIBP knockout zebrafish; endothelial cell overexpression |
| NAXD | Neurometabolic disorder | NAXD knockout cell lines; metabolite profiling |
| HIF1A | Hypoxia signaling in cancer | HIF1A reporter cells; CRISPR activation |
Hepatocellular Carcinoma
Downregulation of NAD(P)HX epimerase (NAXE) promotes tumor progression in hepatocellular carcinoma through ROS/HIF-1α signaling. Loss of NAXE leads to accumulation of damaged NAD(P)H, increased reactive oxygen species, and activation of HIF-1α, which drives angiogenesis and metabolic reprogramming.
NAD(P)HX Repair Deficiency
Mutations in NAXE cause a rare neurometabolic disorder characterized by failure to repair damaged NAD(P)H, leading to impaired de novo serine synthesis and neurological symptoms. This highlights the essential role of the epimerase in human health.
Cardiovascular Disease and Angiogenesis
The moonlighting function of NAXE (AIBP) in cholesterol efflux and angiogenesis links it to atherosclerosis and cardiovascular disease. AIBP regulates lipid metabolism and endothelial cell function, independent of its epimerase activity.
From NAD(P)HX epimerase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NAXE loss promote tumor growth? | NAXE knockout cancer cell lines (e.g., HepG2) and mouse xenografts |
| What is the catalytic mechanism of epimerization? | Recombinant NAXE protein with point mutations in active site |
| How does NAXE moonlight in lipid metabolism? | Knock-in of catalytically dead NAXE in cells |
| What are the metabolic consequences of NAD(P)HX accumulation? | NAXE/NAXD double knockout cells; metabolomics |
| Can NAXE overexpression rescue disease phenotypes? | NAXE overexpression in patient fibroblasts |
| What genes synthetically interact with NAXE? | Genome-wide CRISPR library screening in NAXE KO cells |
How to Study the NAD(P)HX epimerase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | Epimerase activity | Kinetic characterization of NAXE mutants |
| LC-MS metabolomics | NADHX/NADPHX levels | Assessing repair deficiency in cells |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identifying pathways compensating for NAXE loss |
| RNA-seq | Transcriptional changes | Measuring HIF-1α target genes upon NAXE loss |
| Western blot | Protein expression | Validating NAXE knockdown/overexpression |
| Immunoprecipitation | Protein-protein interactions | Detecting AIBP-APOA1 binding |
| Seahorse assay | Glycolysis and respiration | Metabolic phenotyping of NAXE KO cells |
| ROS detection | Reactive oxygen species | Linking NAXE loss to oxidative stress |
Enzymatic Assays
NAD(P)HX epimerase activity can be measured using purified recombinant enzyme and synthetic (6R)-NADHX or (6R)-NADPHX substrates, monitoring the conversion to (6S) epimers by HPLC or mass spectrometry.
Metabolomics
Targeted metabolomics can quantify NADHX, NADPHX, NADH, and NADPH levels in cells or tissues to assess the impact of NAXE loss or overexpression.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens in NAXE-deficient cells can identify synthetic lethal partners and pathways that compensate for loss of NAD(P)HX epimerase activity.
Proteomics and Interactomics
Affinity purification coupled to mass spectrometry can reveal interacting partners of NAXE, such as APOA1, and elucidate its moonlighting functions.
How CRISPR Can Be Used to Study GO:0052856 NAD(P)HX epimerase activity
Knockout
CRISPR knockout of NAXE in cancer cell lines (e.g., HepG2) can model the downregulation observed in hepatocellular carcinoma and reveal its role in tumor progression. Knockout of NAXD can complement these studies to dissect the repair pathway.
Point Mutation
Introducing point mutations in the catalytic residues of NAXE can separate its epimerase activity from its moonlighting functions in lipid metabolism. This is crucial for understanding structure-function relationships.
Knock-in
Knock-in of patient-derived NAXE mutations (e.g., those causing NAD(P)HX repair deficiency) into cell lines allows modeling of the disease and testing of therapeutic interventions.
Overexpression
Overexpression of wild-type or mutant NAXE can rescue phenotypes associated with its loss, such as impaired serine synthesis or increased ROS. It also helps study its moonlighting role in angiogenesis.
How EDITGENE Supports NAD(P)HX epimerase activity Research
Researchers studying NAD(P)HX epimerase activity-related genes often need to determine whether a candidate gene is causally involved in metabolite repair, cancer progression, or lipid metabolism. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for NAD(P)HX epimerase activity research.
Frequently Asked Questions About NAD(P)HX epimerase activity
What is NAD(P)HX epimerase activity?
It is the enzyme activity that converts (6R)-NADHX to (6S)-NADHX and (6R)-NADPHX to (6S)-NADPHX, repairing damaged NADH/NADPH.
What genes are involved in NAD(P)HX epimerase activity?
The primary gene is NAXE (also known as AIBP), which encodes the epimerase. NAXD encodes the downstream dehydratase.
What is the GO ID for NAD(P)HX epimerase activity?
The Gene Ontology ID is GO:0052856.
How is NAD(P)HX epimerase activity related to cancer?
Downregulation of NAXE promotes hepatocellular carcinoma progression through ROS/HIF-1α signaling.
What diseases are associated with NAXE mutations?
Mutations in NAXE cause NAD(P)HX repair deficiency, a rare neurometabolic disorder.
What is the moonlighting function of NAXE?
NAXE (AIBP) also regulates cholesterol efflux, angiogenesis, and lipid metabolism independent of its epimerase activity.
How can I study NAD(P)HX epimerase activity?
Use enzymatic assays with recombinant protein, metabolomics to measure NADHX/NADPHX, and CRISPR knockout models.
What is the role of NAD(P)HX epimerase in serine synthesis?
Failure to repair damaged NAD(P)H blocks de novo serine synthesis in human cells.
Is NAXE the same as AIBP?
Yes, NAXE is also known as AIBP (apolipoprotein A-I binding protein).
What CRISPR models are available for NAXE?
Knockout, point mutation, knock-in, and overexpression models can be generated to study NAXE function.
Conclusion
NAD(P)HX epimerase activity (GO:0052856) is a vital metabolite repair function that maintains NADH/NADPH pools and supports cellular metabolism. Its dysfunction is linked to cancer and neurometabolic disease, while its moonlighting roles in lipid metabolism and angiogenesis expand its physiological importance. CRISPR-based models are indispensable for dissecting these dual functions and developing therapeutic strategies.
References
- 1. Sun B et al.. 2021. NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.. Cancer Sci 112(7):2753-2769 PMID: 33932069
- 2. Niehaus TD et al.. 2018. Evidence that the metabolite repair enzyme NAD(P)HX epimerase has a moonlighting function.. Biosci Rep 38(3) PMID: 29654173
- 3. Qiu X et al.. 2020. AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis.. Curr Atheroscler Rep 23(1):1 PMID: 33230630
- 4. Sorci-Thomas MG et al.. 2017. AIBP, NAXE, and Angiogenesis: What's in a Name?. Circ Res 120(11):1690-1691 PMID: 28546345
- 5. Walvekar AS et al.. 2025. Failure to repair damaged NAD(P)H blocks de novo serine synthesis in human cells.. Cell Mol Biol Lett 30(1):3 PMID: 39789421
- 6. Kim JD et al.. 2022. AIBP Regulates Metabolism of Ketone and Lipids but Not Mitochondrial Respiration.. Cells 11(22) PMID: 36429071
